Objective: To evaluate the incidence of anti-nucleosome antibodies (AnuA) in patients with systemic lupus erythematosus (SLE), its association with anti-nuclear antibodies (ANA), anti-double stranded DNA (anti-dsDNA) and to correlate them with disease activity.